Pomelo Care Valuation, Funding & Investors

Pomelo Care is valued at $1.7B as of January 2026.

Last Pomelo Care valuation

$1.7B

Series C · Jan 2026

Last Pomelo Care funding round

$92M

Series C · Jan 2026

Cumulative funding Pomelo Care raised

$179M

across 4 funding rounds

Key investors in Pomelo Care

  • Andreessen Horowitz
  • SV Angel
  • BoxGroup
  • First Round Capital
  • Operator Partners
  • Stripes

Pomelo Care Overview

About Pomelo Care

Pomelo Care is a San Francisco-headquartered provider of virtual maternity care serving employers and health plans nationwide. The company offers 24/7 clinical support from preconception through the infant's first year, combining telemedicine with in-person doula visits. Pomelo employs data analytics to manage risks in high-need pregnancies, partnering with commercial insurers and Medicaid programs to enhance maternal health outcomes.


Founded

2021

HQ

United StatesNew York City, NY

Status

Privately held

Customer focus

B2B

Revenue model

Services

Valuation

$1.7B (Jan 2026)

Pomelo Care Valuation

Pomelo Care is currently valued at $1.7B, based on its Series C in January 2026.

The $92M round was led by Stripes, with participation from Plus Capital, SV Angel, BoxGroup, Andreessen Horowitz and Atomico.

Pomelo Care valuation by funding round

Pomelo Care valuation by funding round
DateStageValuation
Jan 2026Series C$1.7B

Pomelo Care Funding History

Pomelo Care has raised a total of $179M across 4 funding rounds.

Pomelo Care's first fundraising round was a $8M seed round in September 2021. The most recent completed round was a $92M Series C in January 2026.

Pomelo Care funding rounds

Pomelo Care funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Jan 2026Series CStripes (lead); Plus Capital; SV Angel; BoxGroup; Andreessen Horowitz; Atomico$92M$1.7BPomelo Care is a virtual healthcare company founded in 2021, specializing in evidence-based care for women and children, initially focused on maternity care to improve maternal outcomes and reduce costs for health plans and employers. The company raised $92 million in its Series C funding round led by Stripes, with participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel, achieving a post-money valuation of $1.7 billion. This marks its largest round to date, following prior raises including a $46 million Series B and $33 million Seed/Series A. Pomelo Care has achieved significant scale, covering more than 25 million lives through partnerships with commercial and Medicaid health plans nationwide and supporting nearly 7% of all U.S. births via a 24/7 virtual care model delivered by a multispecialty clinical team. The platform demonstrates strong clinical results, including reductions in preterm births, NICU admissions, emergency visits, and a 718% increase in prenatal depression screening and follow-up rates. Payer engagement yields a 3-5x return on investment, driven by lower high-cost events. With the new funding, Pomelo plans to expand beyond maternity into broader women's and children's health, including pediatrics, reproductive and hormonal health, perimenopause, menopause, and long-term preventive care. Early results from its midlife care program show an 88% reduction in menopause symptoms over 60 days and 73% of patients reporting improved productivity. Investors highlight Pomelo's rapid national scale and potential to transform healthcare delivery across the ecosystem.
Jun 2024Series BAndreessen Horowitz (lead); First Round Capital (lead); SV Angel; Puneet Singh; BoxGroup; Adam Boehler; Operator Partners; Stripes$46M-Pomelo Care is a virtual medical practice focused on improving maternal and newborn health outcomes through personalized, proactive 24/7 care from multispecialty teams including obstetricians, pediatricians, nurses, dieticians, and therapists. The company analyzes claims and health record data to identify high-risk patients and provides care from preconception through an infant's first year, serving as a supplement to primary OBGYN visits with services available via text, phone, or video outside traditional hours. It partners with commercial and Medicaid health plans like Penn Medicine, Koch Industries, and Elevance Health in states including Texas, Tennessee, Kentucky, and Georgia, covering over 3 million lives across 46 states with all value-based contracts. On June 20, 2024, Pomelo Care announced $46 million in Series B financing led by First Round Capital and Andreessen Horowitz (a16z) Bio + Health, with participation from Stripes, BoxGroup, Operator Partners, SV Angel, and angels including Adam Boehler and Puneet Singh, bringing total funding to $79 million. The funds will scale the care model, expand payer partnerships, grow headcount in clinical, operating, data, and engineering teams, and reach more patients nationwide. Research presented at the ACOG meeting showed the model reduced preeclampsia risk by 25%, increased mental health screening rates sevenfold, and lowered perinatal depression risk by 40% in Medicaid populations. Pomelo has demonstrated scale through partnerships enabling collaboration with OB providers, labor and delivery wards, and NICUs, serving hundreds of thousands of expecting mothers and newborns. Subsequent to this round, in a later Series C, the company raised $92 million led by Stripes with a16z and others, achieving a $1.7 billion valuation and total funding of about $171 million, to extend its evidence-based approach beyond maternity.
Jun 2023Series AAndreessen Horowitz (lead); First Round Capital (lead); SV Angel; Puneet Singh; BoxGroup; Adam Boehler; Allen & Company; Operator Partners$33M-Pomelo Care is a virtual maternal and infant health medical practice that delivers value-based care from preconception through a baby's first year. The New York-based company provides comprehensive services including nutrition counseling, educational content, primary and women's healthcare, and 24/7 access to a multi-specialty care team via telephone, text, or video. Pomelo partners with employers, health plans, and academic medical centers to improve maternal and newborn health outcomes and reduce avoidable costs by addressing underlying risk factors. In June 2023, Pomelo Care announced $33 million in combined Seed and Series A funding, comprising $8 million in seed funding and $25 million in Series A funding. Andreessen Horowitz led both rounds, with co-investors including First Round Capital (which co-led the Seed round), SV Angel, Operator Partners, Allen & Company, BoxGroup, Adam Boehler (managing partner of Rubicon Founders), and Puneet Singh (former chief growth officer at Elevance). The company disclosed no post-money valuation for this round. The funding was earmarked for expanding partnerships with health plans, employers, and academic medical centers. Pomelo's customer base at that time included Penn Medicine, Mount Sinai Health System, Koch Industries, Elevance Health, Healthy Blue Nebraska, and Nebraska Total Care. The company stated it was targeting expansion in Medicaid populations and rural geographies where maternal care access is limited and outcomes need improvement, with CEO Marta Bralic Kerns noting that Pomelo was well-capitalized and did not anticipate needing additional capital for the next couple of years.
Sep 2021SeedSV Angel; First Round Capital; BoxGroup; Andreessen Horowitz; Operator Partners$8M--

Who has invested in Pomelo Care?

11 investors have backed Pomelo Care across its funding rounds, including Andreessen Horowitz, SV Angel, BoxGroup, First Round Capital, Operator Partners and Stripes.

Lead investors include Stripes, Andreessen Horowitz and First Round Capital.


Pomelo Care Investors

Investors in Pomelo Care by funding rounds participated
InvestorHQRoundsRoleFirst check
SV AngelUnited StatesSan Francisco, CA4ParticipantSep 2021
BoxGroupUnited StatesNew York City, NY4ParticipantSep 2021
Andreessen HorowitzUnited StatesSan Francisco, CA4LeadSep 2021
First Round CapitalUnited StatesPhiladelphia, PA3LeadSep 2021
Operator PartnersUnited StatesNew York City, NY3ParticipantSep 2021
Puneet SinghUnited StatesNashville, TN2ParticipantJun 2023
Adam BoehlerUnited StatesNashville, TN2ParticipantJun 2023
StripesUnited StatesNew York City, NY2LeadJun 2024
Plus CapitalUnited StatesLos Angeles, CA1ParticipantJan 2026

This data is available for Pro users. Sign up to see all 11 Pomelo Care investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Pomelo Care

Pomelo Care has acquired 1 company to date.

Last acquisition by Pomelo Care was on September 24th 2024. Pomelo Care acquired The Doula Network for undisclosed valuation.


Latest Acquisitions by Pomelo Care

The Doula Network
Description
The Doula Network is a New York-based collective empowering birth doulas with certification, business training, and reimbursement advocacy for Medicaid and insurance coverage. It connects doulas to hospitals and clinics nationwide. Launched in 2020, the network supports over 500 doulas serving diverse populations in maternal health equity initiatives.
HQ CountryUnited States
HQ City
Orlando, FL
Deal Date24 Sep 2024
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Pomelo Care acquisitions and their M&A valuation multiples.

Start Free Trial

Pomelo Care Competitors

Pomelo Care competitors include listed companies like GoodRx and Ping An Healthcare, and private ones like Grand Rounds, Transcarent, Kindbody and DispatchHealth.

Public and private companies comparable to Pomelo Care
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Grand RoundsUnited StatesSan Francisco, CAPrivate--$1.3B-
TranscarentUnited StatesSan Francisco, CAPrivate$50M-$2.2B44.0x
GoodRxUnited StatesUnited StatesPublicly listed$797M$173M$1.2B1.8x
KindbodyUnited StatesNew York City, NYPrivate$180M-$612M3.4x
DispatchHealthUnited StatesDenver, COPrivate--$1.7B-
Ping An HealthcareChinaChinaPublicly listed$815M$52M$1.6B0.9x

Pomelo Care Public Comps

Pomelo Care is still privately-owned, but its public comps include Ping An Healthcare, JMDC, Progyny, GoodRx, Teladoc, Pluxee, Clover Health, Eurowag, Talkspace and Hapvida.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Ping An Healthcare$815M$52M0.9x0.9x13.4x16.9x
JMDC$324M$88M5.0x4.6x18.4x17.9x
Progyny$1.3B$90M1.4x1.4x20.6x8.0x
GoodRx$797M$173M1.8x1.8x8.1x5.5x
Teladoc$2.5B$124M0.6x0.6x11.3x5.0x
Pluxee$1.5B$500M----
Clover Health$1.9B($84M)1.1x0.8x(25.8x)34.1x
Eurowag$2.7B$119M0.5x3.0x10.3x7.5x

This data is available for Pro users. Sign up to see all Pomelo Care competitors and their valuation data.

Start Free Trial

Common questions about Pomelo Care

When was Pomelo Care founded?Pomelo Care was founded in 2021.
Where is Pomelo Care headquartered?Pomelo Care is headquartered in New York City, NY, United States.
Is Pomelo Care publicly listed?No, Pomelo Care is a private, VC-backed company.
What is Pomelo Care's valuation?Pomelo Care was last valued at $1.7B in its Series C in January 2026.
How much funding has Pomelo Care raised?Pomelo Care has raised $179M across 4 funding rounds.
What was Pomelo Care's last funding round?Pomelo Care's last funding round was a $92M Series C in January 2026, led by Stripes.
Who are Pomelo Care's investors?Pomelo Care's investors include SV Angel, BoxGroup, Andreessen Horowitz, First Round Capital, Operator Partners, Puneet Singh, Adam Boehler, Stripes, Plus Capital, Allen & Company and 1 other.
Which companies are comparable to Pomelo Care?Companies comparable to Pomelo Care include Grand Rounds, Transcarent, GoodRx, Kindbody, DispatchHealth and Ping An Healthcare.
How many companies has Pomelo Care acquired?Pomelo Care has acquired 1 company, including The Doula Network.

See companies similar to Pomelo Care

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial